BioCentury
ARTICLE | Clinical News

Columbia regulatory update

June 19, 1995 7:00 AM UTC

Columbia Laboratories Inc. (COB) COB's Crinone natural progesterone received U.K. marketing approval to prevent hyperplasia and endometrial cancer in postmenopausal women receiving hormone replacemen...